Literature DB >> 15763446

Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?

O Nishiyama1, H Taniguchi, Y Kondoh, T Kimura, T Ogawa, F Watanabe, K Nishimura.   

Abstract

The prognosis of patients with idiopathic pulmonary fibrosis (IPF) is generally considered to be poor. As the disease progresses, patients invariably become severely limited in their activities. Therefore, evaluating the health-related quality of life (HRQoL) in IPF patients is considered to be important. However, there have been few studies of this kind to date. We applied the St. George's Respiratory Questionnaire (SGRQ) to 41 consecutive IPF patients and examined various physiological variables to identify factors that were correlated with the HRQoL. Total lung capacity, transfer factor, arterial partial pressure of oxygen at rest, the lowest oxygen saturation during exercise test, and the baseline dyspnoea index (BDI) score were significantly correlated with the total SGRQ score. A similar tendency was observed in each component. Conversely, peak oxygen uptake, known as one of the important factors that determines HRQoL in chronic obstructive pulmonary disease (COPD), did not correlate with any SGRQ scores. In stepwise multiple regression analysis, the BDI score was selected as the only factor significantly contributing to the total SGRQ score. Dyspnoea was the most important factor determining HRQoL in IPF. The types of other variables that correlated with the HRQoL in IPF patients were different from those in COPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763446     DOI: 10.1016/j.rmed.2004.09.005

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  48 in total

1.  Assessing dyspnea and its impact on patients with connective tissue disease-related interstitial lung disease.

Authors:  Jeffrey J Swigris; Janelle Yorke; David B Sprunger; Christopher Swearingen; Theodore Pincus; Roland M du Bois; Kevin K Brown; Aryeh Fischer
Journal:  Respir Med       Date:  2010-05-14       Impact factor: 3.415

2.  Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis: comparison with chronic obstructive pulmonary disease.

Authors:  Shinichi Arizono; Hiroyuki Taniguchi; Koji Sakamoto; Yasuhiro Kondoh; Tomoki Kimura; Kensuke Kataoka; Tomoya Ogawa; Fumiko Watanabe; Kazuyuki Tabira; Ryo Kozu
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Patient-reported outcomes in idiopathic pulmonary fibrosis research.

Authors:  Jeffrey J Swigris; Diane Fairclough
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

4.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 5.  Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.

Authors:  J J Swigris; W G Kuschner; S S Jacobs; S R Wilson; M K Gould
Journal:  Thorax       Date:  2005-07       Impact factor: 9.139

6.  The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Meilan Han; Rekha Vij; Imre Noth; Eric L Eisenstein; Kevin J Anstrom; Kevin K Brown; Diane Fairclough
Journal:  Respir Med       Date:  2012-07-15       Impact factor: 3.415

7.  Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

Authors:  Janelle Yorke; Jeffrey Swigris; Anne-Marie Russell; Shakeeb H Moosavi; Georges Ng Man Kwong; Mark Longshaw; Paul W Jones
Journal:  Chest       Date:  2010-07-01       Impact factor: 9.410

8.  Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire.

Authors:  Janelle Yorke; Paul W Jones; Jeffrey J Swigris
Journal:  Thorax       Date:  2010-10       Impact factor: 9.139

9.  Health-related quality of life and 6 min walk distance in patients with idiopathic pulmonary fibrosis.

Authors:  Geetika Verma; Theodore Marras; Nouri Chowdhury; Lianne Singer
Journal:  Can Respir J       Date:  2011 Sep-Oct       Impact factor: 2.409

10.  Effect of lung fibrosis on glycogen content in different extrapulmonary tissues.

Authors:  Elizabeth Lage Borges; Marina de Barros Pinheiro; Luana Oliveira Prata; Wesley Araújo Sales; Yuri Augusto Junqueira Belém Silva; Marcelo Vidigal Caliari; Maria Glória Rodrigues-Machado; Maria da Glória Rodrigues-Machado
Journal:  Lung       Date:  2013-12-03       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.